Sonoma Pharmaceuticals, Inc. Logo

Email this page: News Release

Sonoma Pharmaceuticals Announces FDA Approval of Expanded Indication for Alevicyn™ to Add Antimicrobial Language

 

Separate multiple addresses with commas. Maximum 200 characters.
 
 


These email addresses will be used to email the page on your behalf and will not be used by Sonoma Pharmaceuticals, Inc. for any marketing purposes.

Send:       


 
This helps Sonoma Pharmaceuticals, Inc. prevent automated submissions.